Since the disease is associated with polymorphic AR and ERbeta variants that are presumed to be linked to weaker hormone signaling, it may suggest that an incorrect hormonal balance might increase the cardiovascular risk of acromegaly subjects. This evidence concerns the gene AR and acromegaly.